Autonomy on Trial

Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualistic model dominant in American legal doctrine with relational, duty-oriented frameworks found in parts of Asia and Europe. Analyzing landmark US cases—Cruzan v. Director, Missouri Dept. of Health, In re A.C., and Addington v. Texas—alongside bioethics scholarship, the paper highlights both the strengths and limitations of a legalistic approach to medical decision making. Drawing on comparative literature from India, China, Singapore, and several European nations, it explores how familial, cultural, and institutional norms shape the exercise of autonomy abroad. The paper argues that the American focus on individual consent and procedural safeguards can undermine trust in clinical relationships and neglect the social dimensions of care. It ultimately advocates for a more pluralistic model that integrates legal protections with relational ethics and calls for reforms to capacity standards, consent processes, and advance directives that respect cultural values while upholding patient rights. Introduction Patient autonomy has long been regarded as a cornerstone of US medical ethics. It is enshrined in law and policy as the basic right of individuals to make decisions about their own health care. In practice, however, legal cases and bioethics debates reveal tension between a formal, rights-based notion of autonomy and the relational values that many patients and cultures embrace. This paper examines how US law and policy interpret and enforce patient autonomy in contrast to relational approaches found in much of Asia and Europe. By analyzing landmark US court decisions and bioethics scholarship, this paper shows how American law practice often treats autonomy as an individualistic, legalistic matter that can sometimes undermine trust in the doctor-patient relationship. By comparison, many Asian and some European models emphasize duties, family involvement, and communal values in decision making. Critics argue that the American approach can reduce patients to processors of information rather than complex persons with relationships and values. In practice, a legalistic checklist for informed consent may prevail, sometimes at the expense of trust and empathy. In sum, US bioethics and law emphasize individual choice, formal consent, and evidentiary standards. The prevailing model assumes an atomistic patient who holds rights (and responsibilities) to demand or refuse treatment, shielded by due process. This approach certainly protects autonomy on paper, but it may neglect the social and cultural dimensions of decision making. Some bioethicists caution that we must ask whether “moral claims that ought to be made into legal rights” are better served by courts or by ethical dialogue.[1] Before turning to alternative models, we should acknowledge both the value and limits of the current, rights-based framework. It clearly delineates patient entitlements and uses legal procedures to safeguard choices, but it may also narrow the focus to rules over relationships. Autonomy in US Law and Bioethics In US health law, patient autonomy is largely enforced through formal rules about informed consent and decision-making capacity. Under American jurisprudence, a competent adult generally has a constitutional right to refuse medical treatment.[2] For example, in In re A.C., a DC court emphatically held that even a pregnant woman has “the right to refuse medical treatment for herself and the fetus.”[3] If a patient is incapacitated, courts attempt to honor her wishes, for example, by substituted judgment or by appointing a surrogate decision maker in accordance with state law. They do not consistently defer to the state’s interest in preserving life. Similarly, Lane v. Candura affirmed that a competent elderly patient “has the right under the law to refuse to submit either to medical treatment or a surgical operation” — a decision that, though deemed unwise by her physicians, could not be overridden absent a finding of legal incompetence.[4] Notably, however, conflicts still arise. In 2025, for example, a hospital in Georgia kept a brain-dead pregnant woman on life support for months to allow her fetus to develop, citing a strict state fetal-protection law[5] – an outcome that shows the discrepancy between DC caselaw and the Georgia statute. [6] These cases illustrate an emphasis on informed consent: the patient’s decision (or presumed decision, if competent) must prevail unless clear evidence shows incapacity or a compelling state interest. Yet the Georgia case may indicate a trend toward failing to respect autonomy. The US Supreme Court has reinforced respect for autonomy while also permitting robust state oversight in borderline cases. In Cruzan, the Court recognized a federal constitutional right to refuse unwanted life-sustaining treatment. However, it also held that states may require “clear and convincing” evidence of the patient’s wishes before allowing withdrawal of care. American law treats autonomy as a fundamental principle but subjects it to procedural safeguards. Likewise, in the involuntary commitment context, the Court balanced individual liberty against state interests by mandating a clear-and-convincing standard of proof for committing someone to a mental institution.[7] In Addington v. Texas, the Court insisted that due process requires more than a mere preponderance of evidence before depriving a person of liberty for psychiatric care, yet it declined to impose the criminal “beyond a reasonable doubt” standard. These rulings demonstrate that American law approaches life-and-death health care decisions as matters to be resolved through formal legal procedures, applying rules of evidence and capacity assessments. This legal framing ensures a degree of rigor and consistency in protecting patients’ rights, but it also reflects the tendency to translate deeply personal and complex medical dilemmas into technical legal questions. Importantly, the point is not to dispute the right to refuse treatment; rather, patients have the tool of resorting to courts and invoking legal procedures to ensure their ability to exercise their rights and to investigate limitations on them. Clinicians and hospital systems also look to courts to resolve issues. Some scholars suggest that other, less adversarial approaches might equally protect patient choice while better addressing the human and ethical dimensions. Observers have described this legalistic phenomenon as the “language of the law” infiltrating bioethics. “Americans today truly do resolve political — and moral — questions into judicial questions,” [8] adopting trial-style reasoning and formal rights-talk even in intimate healthcare matters. One commentator warns that law’s technical discourse may be “inapt” for addressing ethical concerns, and that the legal process can distort the meaning of concepts like autonomy.[9] Similarly, an influential framework for assessing decision-making capacity analyzes ability in strictly cognitive terms. Capacity is defined as the ability to (a) understand information, (b) appreciate its significance for oneself, (c) reason about treatment options, and (d) communicate a choice. These four domains, drawn from case law and psychology, form the threshold for valid consent or refusal. In the US model, a patient lacking capacity cannot make certain binding decisions; instead, a surrogate decision maker, often a family member, or, in some cases, a state-appointed guardian steps in. This rights-based framework has virtues of clarity and fairness, but as critics note, translating every serious medical decision into a legal checklist can overlook the human context of care. International and Relational Perspectives on Autonomy Across Asia and Europe, many healthcare systems cast autonomy in a more relational or duty-embedded light. Cultural traditions, legal norms, and ethical theories in these contexts often emphasize family, community, and physician responsibilities rather than treating the patient as a solitary rights-bearer. One scholar observes that the very “principle of respect for autonomy” originated in Western bioethics and may not fit seamlessly into other cultures. Indeed, many critics view individual autonomy as “only applicable in the West,” contrasting it with the family- and community-oriented decision making typical in Eastern societies.[10] Informed consent itself is often seen as a Western import that requires cultural adaptation. One ethicist calls for “glocal” flexibility—an Aristotelian “Lesbian rule”—allowing bioethical principles to bend to local contexts. This perspective suggests that autonomy must be understood in light of social roles and trust networks, not assumed to be universal by US standards. In India, for example, bioethicists tend to “reject the primacy of autonomy,” instead empowering courts to protect vulnerable patients even against the wishes of patients or families.[11] In practice, families and physicians often make decisions collectively, and courts may override refusals of treatment in the name of preserving life. Notably, one study suggests the Indian model does not necessarily reflect grassroots values but is partly a product of colonial legacy and legal conservatism., The author of that study critiques a competing bioethics in which courts and clinicians frame social vulnerability as mere “sociomoral underdevelopment,” cautioning that paternalism can masquerade as protection.[12] Elsewhere in Asia, similar themes appear. In China, traditional Confucian ethics emphasize familial harmony and deference to authority. One survey of Chinese clinicians and ethicists reported widespread acceptance of “benevolent deception” — doctors withholding information from patients to avoid distress, with the family’s blessing.[13] Likewise, a